BG Medicine Outlines New Commercial Strategy
November 13, 2012 07:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today provided an...
BG Medicine Reports Third Quarter 2012 Financial Results and Provides Business Update
November 13, 2012 07:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today reported financial results for the third quarter ended September 30, 2012 and provided a business...
BG Medicine, Inc. to Present at Lazard Capital Markets 9th Annual Healthcare Conference
November 09, 2012 16:45 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Medicine Announces Data Analyses Presented at American Heart Association Meeting
November 09, 2012 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that...
BG Medicine Announces Decision by American Medical Association and Centers for Medicare and Medicaid Services on Analyte-Specific CPT(R) Code and Reimbursement for BGM Galectin-3(R) Test
November 07, 2012 08:09 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Medicine to Announce Third Quarter 2012 Earnings Results and Commercial Strategy Update and Host Conference Call on Tuesday, November 13, 2012
November 07, 2012 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Tuesday, November 13 at 8:00 a.m. Eastern...
BG Medicine to Highlight Role of Galectin-3 Testing in Reducing Unplanned Hospital Readmissions at the 2012 American Heart Association (AHA) Scientific Sessions
November 05, 2012 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass. and LOS ANGELES, Nov. 5, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today...
BG Medicine Announces Agreement With Kindstar Diagnostics Which Will Provide Galectin-3 Testing Services in China
October 24, 2012 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Oct. 24, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Medicine, Inc. Appoints Charles H. Abdalian, Jr. as Chief Financial Officer
October 18, 2012 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Oct. 18, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Announces Key Additions to Senior Management Team
September 11, 2012 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Sept. 11, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...